# Sigrid Lundberg

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sigrid-lundberg/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,266 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 21 |
| i10-index | 33 |
| Last Known Institution | Karolinska University Hospital |
| OpenAlex ID | https://openalex.org/A5026109229 |
| ORCID iD | 0000-0003-1224-5200 |
| Works | 70 |

## Researcher papers

- [The MEST score provides earlier risk prediction in lgA nephropathy](https://scholariq.org/papers/the-mest-score-provides-earlier-risk-prediction-in-lga-nephropathy/)
- [Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy](https://scholariq.org/papers/results-from-part-a-of-the-multi-center-double-blind-randomized-placebo/)
- [Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy](https://scholariq.org/papers/genome-wide-association-analyses-define-pathogenic-signaling-pathways-and/)
- [Mortality in IgA Nephropathy: A Nationwide Population-Based Cohort Study](https://scholariq.org/papers/mortality-in-iga-nephropathy-a-nationwide-population-based-cohort-study/)
- [Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update](https://scholariq.org/papers/is-there-long-term-value-of-pathology-scoring-in-immunoglobulin-a-nephropathy-a/)
- [Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy](https://scholariq.org/papers/development-and-testing-of-an-artificial-intelligence-tool-for-predicting-end/)
- [Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy](https://scholariq.org/papers/association-of-soluble-cd89-levels-with-disease-progression-but-not/)
- [Circulating Anti–Glomerular Basement Membrane Antibodies With Predominance of Subclass IgG4 and False-Negative Immunoassay Test Results in Anti–Glomerular Basement Membrane Disease](https://scholariq.org/papers/circulating-anti-glomerular-basement-membrane-antibodies-with-predominance-of/)
- [Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort](https://scholariq.org/papers/risk-factors-for-progression-in-children-and-young-adults-with-iga-nephropathy/)
- [Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy](https://scholariq.org/papers/tonsillectomy-in-a-european-cohort-of-1-147-patients-with-iga-nephropathy/)
- [Primary glomerular diseases and long‐term adverse health outcomes: A nationwide cohort study](https://scholariq.org/papers/primary-glomerular-diseases-and-long-term-adverse-health-outcomes-a-nationwide/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)

## Researcher university

- [Karolinska University Hospital](https://scholariq.org/institutions/karolinska-university-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.